Details of the Drug Formulations

General Information of Drug (ID: DMYURI6)

• Drug Name: Raltegravir Drug Info
• Synonyms: RGV; MK 0518; Isentress(TM); K-0518; MK-0518; Raltegravir (INN); N-(2-(4-(4-fluorobenzylcarbamoyl); N-((4-Fluorophenyl)methyl)-1,6-dihydro-5-hydroxy-1-methyl-2-(1-methyl-1-(((5-methyl-1,3,4-oxadiazol-2-yl)carbonyl)amino)ethyl)-6-oxo-4-pyrimidinecarboxamide; RAL

Indication

Disease Entry	ICD 11	Status	REF
Human immunodeficiency virus infection	1C62	Approved	[1]

• Cross-matching ID:
  PubChem CID: 54671008
  CAS Number: 518048-05-0
  TTD ID: D0I1FQ
  INTEDE ID: DR1390
  ACDINA ID: D00580

Full List of Drug Formulations Containing This Drug

Raltegravir 100 mg tablet

Company	Formulation ID	FDA Description
Merck Sharp & Dohme	F18691	Oleic acid; Ammonium glycyrrhizate; Sodium stearyl fumarate; Sucralose; Aspartame; Fructose; Magnesium stearate; Mannitol; Sorbitol; Ammonia; Ferric oxide red; Ferric oxide yellow; Trisodium citrate dihydrate; Medium-chain triglycerides; Polyethylene glycol 400; Crospovidone (15 mpa.s at 5%); Ethylcellulose (20 mpa.s); Hydroxypropyl cellulose (1200000 mw); Hypromellose 2910 (6 mpa.s); Saccharin sodium

Raltegravir 25 mg tablet

Company	Formulation ID	FDA Description
Merck Sharp & Dohme	F18692	Oleic acid; Ammonium glycyrrhizate; Sodium stearyl fumarate; Sucralose; Aspartame; Fructose; Magnesium stearate; Mannitol; Sorbitol; Ammonia; Ferric oxide yellow; Trisodium citrate dihydrate; Medium-chain triglycerides; Polyethylene glycol 400; Crospovidone (15 mpa.s at 5%); Ethylcellulose (20 mpa.s); Hydroxypropyl cellulose (1200000 mw); Hypromellose 2910 (6 mpa.s); Saccharin sodium

Raltegravir 400 mg tablet

Company	Formulation ID	FDA Description
State of Florida DOH Central Pharmacy	F18693	Lactose monohydrate; Butylated hydroxytoluene; Sodium stearyl fumarate; Magnesium stearate; Anhydrous dibasic calcium phosphate; Ferric oxide red; Ferrosoferric oxide; Talc; Titanium dioxide; Hypromellose; Poloxamer 407; Polyethylene glycol 3350; Polyvinyl alcohol; Cellulose, microcrystalline
Physicians Total Care	F18695	Lactose monohydrate; Butylated hydroxytoluene; Sodium stearyl fumarate; Magnesium stearate; Anhydrous dibasic calcium phosphate; Ferric oxide red; Ferrosoferric oxide; Talc; Titanium dioxide; Poloxamer 407; Polyethylene glycol 3350; Polyvinyl alcohol; Cellulose, microcrystalline; Hypromelloses
A-S Medication Solutions; Merck Sharp & Dohme; RemedyRepack	F18694	Lactose monohydrate; Butylated hydroxytoluene; Sodium stearyl fumarate; Magnesium stearate; Anhydrous dibasic calcium phosphate; Ferric oxide red; Ferrosoferric oxide; Talc; Titanium dioxide; Poloxamer 407; Polyethylene glycol 3350; Hypromellose, unspecified; Microcrystalline cellulose; Polyvinyl alcohol, unspecified
A-S Medication Solutions; Avera McKennan Hospital; Dispensing Solution; NuCare Pharmaceuticals; RemedyRepack	F18696	Lactose monohydrate; Butylated hydroxytoluene; Sodium stearyl fumarate; Magnesium stearate; Ferric oxide red; Ferrosoferric oxide; Talc; Titanium dioxide; Poloxamer 407; Polyethylene glycol 3350; Polyvinyl alcohol; Calcium phosphate, dibasic, anhydrous; Cellulose, microcrystalline; Hypromelloses

Raltegravir Potassium eq 100mg base/packet powder

Company	Formulation ID	FDA Description
Merck Sharp Dohme	F23528	Ammonium Hydroxide; Banana With Other Natural Flavors; Carboxymethylcellulose Sodium; Crospovidone; Ethylcellulose 20 Cp; Fructose; Hydroxypropyl Cellulose; Hypromellose 2910/6Cp; Macrogol/Peg 400; Magnesium Stearate; Maltodextrin; Mannitol; Medium Chain Triglycerides; Microcrystalline Cellulose; Monoammonium Glycyrrhizinate; Oleic Acid; Sorbitol; Sucralose; Sucrose

Raltegravir Potassium eq 25mg base Chewable tablet

Company	Formulation ID	FDA Description
Merck Sharp Dohme	F23529	Ammonium Hydroxide; Crospovidone; Ethylcellulose 20 Cp; Fructose; Hydroxypropyl Cellulose; Hypromellose 2910/6Cp; Magnesium Stearate; Mannitol; Medium Chain Triglycerides; Monoammonium Glycyrrhizinate; Natural And Artificial Flavors (Orange, Banana, And Masking That Contains Aspartame); Oleic Acid; Peg 400; Saccharin Sodium; Sodium Citrate Dihydrate; Sodium Stearyl Fumarate; Sorbitol; Sucralose And Yellow Iron Oxide; Red Iron Oxide

Raltegravir Potassium eq 100mg base Chewable tablet

Company	Formulation ID	FDA Description
Merck Sharp Dohme	F23530	Ammonium Hydroxide; Crospovidone; Ethylcellulose 20 Cp; Fructose; Hydroxypropyl Cellulose; Hypromellose 2910/6Cp; Magnesium Stearate; Mannitol; Medium Chain Triglycerides; Monoammonium Glycyrrhizinate; Natural And Artificial Flavors (Orange, Banana, And Masking That Contains Aspartame); Oleic Acid; Peg 400; Saccharin Sodium; Sodium Citrate Dihydrate; Sodium Stearyl Fumarate; Sorbitol; Sucralose And Yellow Iron Oxide; Red Iron Oxide

Raltegravir Potassium eq 400mg base tablet

Company	Formulation ID	FDA Description
Merck Sharp Dohme	F23531	Calcium Phosphate Dibasic Anhydrous; Hypromellose 2208; Lactose Monohydrate; Magnesium Stearate; Microcrystalline Cellulose; Poloxamer 407 (Contains 0.01% Butylated Hydroxytoluene As Antioxidant); Sodium Stearyl Fumarate; Black Iron Oxide; Polyethylene Glycol 3350; Polyvinyl Alcohol; Red Iron Oxide; Talc; Titanium Dioxide

Raltegravir Potassium eq 600mg base tablet

Company	Formulation ID	FDA Description
Merck Sharp Dohme	F23532	Croscarmellose Sodium; Hypromellose 2910; Magnesium Stearate; Microcrystalline Cellulose; Ferrosoferric Oxide; Hypromellose 2910; Iron Oxide Yellow; Lactose Monohydrate; Triacetin; Titanium Dioxide; Carnauba Wax

Raltegravir 600 mg tablet

Company	Formulation ID	FDA Description
Merck Sharp & Dohme	F18697	Lactose monohydrate; Magnesium stearate; Ferric oxide yellow; Ferrosoferric oxide; Titanium dioxide; Triacetin; Croscarmellose sodium; Carnauba wax; Hypromellose, unspecified; Microcrystalline cellulose

References

• [1] 2007 FDA drug approvals: a year of flux. Nat Rev Drug Discov. 2008 Feb;7(2):107-9.